Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma

NCT00652041

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Hospital Morales Messeguer Murcia, Spain
  • Hospital Virgen de la Vega Murcia, Spain
  • Hospital de la Diputación de Navarra Navarra, Spain
  • Hospital Clínico de Salamanca Salamanca, Spain
View Trial Details
Completed

GEM05 for Patients With Multiple Myeloma More Than 65 Years Old

NCT00443235

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Royo Villanova Zaragoza, Aragon, Spain
  • Complejo Hospitalario Universitario de Albacete Albacete, Spain
  • Fundación Hospital Alcorcón Alcorcón, Spain
  • Hospital Nuestra Señora de Sonsoles Ávila, Spain
View all 77 locations
View Trial Details
Completed

Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

NCT00273936

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Stanford Cancer Center Stanford, California, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • Ohio State University, James Cancer Hospital Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma

NCT00263484

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Tata Memorial Hospital Mumbai, India
  • Christian Medical College Vellore, Tamil Nadu, India
  • Singapore General Hospital Singapore
  • National Cancer Centre, Singapore Singapore
View Trial Details
Completed

A Multiple Myeloma Trial in Patients With Bone Metastases

NCT00104104

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hematology Oncology Specialists Huntsville, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • US Oncology Tucson, Arizona, United States
  • Myeloma Institute For Research Therapy Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

NCT00546780

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Comprehensive Blood And Cancer Center Bakersfield, California, United States
  • Moores Ucsd Cancer Center La Jolla, California, United States
  • University Of California Medical Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 19 locations
View Trial Details

Related conditions